Conference Paper: Propofol confers postconditioning-like cardioprotection via its peroxynitrite scavenging property

File Download

re01.htm

Supplementary

Citations:
- Scopus:
- Web of Science:
- PubMed Central:
Item Statistics (The Hub)
Appears in Collections:
- Anaesthesiology: Conference papers

Title	Propofol confers postconditioning-like cardioprotection via its peroxynitrite scavenging property
Authors	Mao, X Wong, G Huang, Z Irwin, MG Xia, Z
Issue Date	2011
Publisher	American Society of Anesthesiologists. The Abstract Archive is located at http://www.asaabstracts.com/strands/asaabstracts/abstractArchive.htm
Citation	The 2011 Annual Meeting of the American Society of Anesthesiologists (ASA 2011), Chicago, IL., 15-19 October 2011. In Abstract Archive of the American Society of Anesthesiologists, 2011, abstract no. A537 [How to Cite?]
Abstract	BACKGROUND: Propofol, an intravenous anesthetic that possesses antioxidant and peroxynitrite-scavenging properties, has been shown to confer cardioprotection in both experimental and clinical settings, but the precise mechanism is unclear. Reduction of peroxynitrite production (1) has been shown to play a critical role in hypoxia postconditioning mediated cardioprotection in cultured cardiomyocytes. We, therefore, hypothesize that propofol can confer postconditioning (PPC) cardioprotection via its peroxynitrite scavenging property. METHODS: With ethics approval, isolated and Langendorff-perfused hearts from male Sprague Dawley rats were exposed to 30 min of global ischemia followed by 120 min of reperfusion. During the first 15 min of reperfusion, hearts (n=6-8 per group) were either untreated (control group), or respectively treated with 50 µmol/L of propofol (PPC group), 0.1mmol/ 3-morpholino sydnonimine (SIN-1, a peroxynitrite donor which produces nitric oxide and superoxide anion simultaneously in aqueous solution, SIN group), 20 mg/L of the peroxynitrite decomposer FeTPPs (FeTPPs group), the combinations of propofol with SIN-1 (PPC+SIN) or with FeTPPs (PPC+FeTPPs groups). Myocardial infarct size (IS) was assessed by triphenyltetrazolium staining. Data are expressed as mean ± SD and were analyzed with ANOVA. RESULTS: Postischemic myocardial infarct size (IS) was 36.7±4.7% in the control group. Propofol postconditioning (PPC) significantly reduced IS (28.1±7.0%, P<0.05 vs. control). However, the infarct-sparing effect of PPC was cancelled by co-administration of SIN-1 (IS: 34.5 ±3.9% in PPC+SIN group, P>0.1 vs. control) but facilitated by co-administration of FeTPPs (IS: 15.1±3.8% in PPC+FeTPPs groups, P<0.01 vs. PPC). SIN-1 when given alone during early reperfusion exacerbated postischemic IS (50.9±1.1%, P<0.05 vs. control), while FeTPPs attenuated myocardial IS (21.5 ±8.6%, P<0.01 vs. control). CONCLUSION: It is concluded that propofol can confer postconditioning-like cardioprotection in vitro and that scavenging of peroxynitrite during early reperfusion may represent an important mechanism by which propofol postconditioning confers cardioprotection.
Description	Topic: Experimental Circulation: abstract no. A537

DC Field	Value
dc.contributor.author	Mao, X
dc.contributor.author	Wong, G
dc.contributor.author	Huang, Z
dc.contributor.author	Irwin, MG
dc.contributor.author	Xia, Z
dc.date.accessioned	2012-09-20T08:25:13Z
dc.date.available	2012-09-20T08:25:13Z
dc.date.issued	2011
dc.description.abstract	BACKGROUND: Propofol, an intravenous anesthetic that possesses antioxidant and peroxynitrite-scavenging properties, has been shown to confer cardioprotection in both experimental and clinical settings, but the precise mechanism is unclear. Reduction of peroxynitrite production (1) has been shown to play a critical role in hypoxia postconditioning mediated cardioprotection in cultured cardiomyocytes. We, therefore, hypothesize that propofol can confer postconditioning (PPC) cardioprotection via its peroxynitrite scavenging property. METHODS: With ethics approval, isolated and Langendorff-perfused hearts from male Sprague Dawley rats were exposed to 30 min of global ischemia followed by 120 min of reperfusion. During the first 15 min of reperfusion, hearts (n=6-8 per group) were either untreated (control group), or respectively treated with 50 µmol/L of propofol (PPC group), 0.1mmol/ 3-morpholino sydnonimine (SIN-1, a peroxynitrite donor which produces nitric oxide and superoxide anion simultaneously in aqueous solution, SIN group), 20 mg/L of the peroxynitrite decomposer FeTPPs (FeTPPs group), the combinations of propofol with SIN-1 (PPC+SIN) or with FeTPPs (PPC+FeTPPs groups). Myocardial infarct size (IS) was assessed by triphenyltetrazolium staining. Data are expressed as mean ± SD and were analyzed with ANOVA. RESULTS: Postischemic myocardial infarct size (IS) was 36.7±4.7% in the control group. Propofol postconditioning (PPC) significantly reduced IS (28.1±7.0%, P<0.05 vs. control). However, the infarct-sparing effect of PPC was cancelled by co-administration of SIN-1 (IS: 34.5 ±3.9% in PPC+SIN group, P>0.1 vs. control) but facilitated by co-administration of FeTPPs (IS: 15.1±3.8% in PPC+FeTPPs groups, P<0.01 vs. PPC). SIN-1 when given alone during early reperfusion exacerbated postischemic IS (50.9±1.1%, P<0.05 vs. control), while FeTPPs attenuated myocardial IS (21.5 ±8.6%, P<0.01 vs. control). CONCLUSION: It is concluded that propofol can confer postconditioning-like cardioprotection in vitro and that scavenging of peroxynitrite during early reperfusion may represent an important mechanism by which propofol postconditioning confers cardioprotection.
dc.description.nature	link_to_OA_fulltext
dc.description	Topic: Experimental Circulation: abstract no. A537
dc.identifier.citation	The 2011 Annual Meeting of the American Society of Anesthesiologists (ASA 2011), Chicago, IL., 15-19 October 2011. In Abstract Archive of the American Society of Anesthesiologists, 2011, abstract no. A537 [How to Cite?]
dc.identifier.hkuros	209799
dc.identifier.uri	http://hdl.handle.net/10722/165919
dc.language	eng
dc.publisher	American Society of Anesthesiologists. The Abstract Archive is located at http://www.asaabstracts.com/strands/asaabstracts/abstractArchive.htm
dc.publisher.place	United States
dc.relation.ispartof	Abstract Archive of the American Society of Anesthesiologists
dc.title	Propofol confers postconditioning-like cardioprotection via its peroxynitrite scavenging property
dc.type	Conference_Paper

<?xml encoding="utf-8" version="1.0"?><item><contributor.author>Mao, X</contributor.author><contributor.author>Wong, G</contributor.author><contributor.author>Huang, Z</contributor.author><contributor.author>Irwin, MG</contributor.author><contributor.author>Xia, Z</contributor.author><date.accessioned>2012-09-20T08:25:13Z</date.accessioned><date.available>2012-09-20T08:25:13Z</date.available><date.issued>2011</date.issued><identifier.citation>The 2011 Annual Meeting of the American Society of Anesthesiologists (ASA 2011), Chicago, IL., 15-19 October 2011. In Abstract Archive of the American Society of Anesthesiologists, 2011, abstract no. A537</identifier.citation><identifier.uri>http://hdl.handle.net/10722/165919</identifier.uri><description>Topic: Experimental Circulation: abstract no. A537</description><description.abstract>BACKGROUND: Propofol, an intravenous anesthetic that possesses antioxidant and peroxynitrite-scavenging properties, has been shown to confer cardioprotection in both experimental and clinical settings, but the precise mechanism is unclear. Reduction of peroxynitrite production (1) has been shown to play a critical role in hypoxia postconditioning mediated cardioprotection in cultured cardiomyocytes. We, therefore, hypothesize that propofol can confer postconditioning (PPC) cardioprotection via its peroxynitrite scavenging property. METHODS: With ethics approval, isolated and Langendorff-perfused hearts from male Sprague Dawley rats were exposed to 30 min of global ischemia followed by 120 min of reperfusion. During the first 15 min of reperfusion, hearts (n=6-8 per group) were either untreated (control group), or respectively treated with 50 &#181;mol/L of propofol (PPC group), 0.1mmol/ 3-morpholino sydnonimine (SIN-1, a peroxynitrite donor which produces nitric oxide and superoxide anion simultaneously in aqueous solution, SIN group), 20 mg/L of the peroxynitrite decomposer FeTPPs (FeTPPs group), the combinations of propofol with SIN-1 (PPC+SIN) or with FeTPPs (PPC+FeTPPs groups). Myocardial infarct size (IS) was assessed by triphenyltetrazolium staining. Data are expressed as mean &#177; SD and were analyzed with ANOVA. RESULTS: Postischemic myocardial infarct size (IS) was 36.7&#177;4.7% in the control group. Propofol postconditioning (PPC) significantly reduced IS (28.1&#177;7.0%, P&lt;0.05 vs. control). However, the infarct-sparing effect of PPC was cancelled by co-administration of SIN-1 (IS: 34.5 &#177;3.9% in PPC+SIN group, P&gt;0.1 vs. control) but facilitated by co-administration of FeTPPs (IS: 15.1&#177;3.8% in PPC+FeTPPs groups, P&lt;0.01 vs. PPC). SIN-1 when given alone during early reperfusion exacerbated postischemic IS (50.9&#177;1.1%, P&lt;0.05 vs. control), while FeTPPs attenuated myocardial IS (21.5 &#177;8.6%, P&lt;0.01 vs. control). CONCLUSION: It is concluded that propofol can confer postconditioning-like cardioprotection in vitro and that scavenging of peroxynitrite during early reperfusion may represent an important mechanism by which propofol postconditioning confers cardioprotection.</description.abstract><language>eng</language><publisher>American Society of Anesthesiologists. The Abstract Archive is located at http://www.asaabstracts.com/strands/asaabstracts/abstractArchive.htm</publisher><relation.ispartof>Abstract Archive of the American Society of Anesthesiologists</relation.ispartof><title>Propofol confers postconditioning-like cardioprotection via its peroxynitrite scavenging property</title><type>Conference_Paper</type><description.nature>link_to_OA_fulltext</description.nature><identifier.hkuros>209799</identifier.hkuros><publisher.place>United States</publisher.place><bitstream.url>http://hub.hku.hk/bitstream/10722/165919/1/re01.htm</bitstream.url></item>